Cited by 333Autophagy in Disease and TherapyAlzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration Mechanisms

Autophagy and neurodegeneration

Open access
Frake, Rebecca A., Ricketts, Thomas, Menzies, Fiona M., Rubinsztein, David C.·2015·Journal of Clinical Investigation

Abstract

Most neurodegenerative diseases that afflict humans are associated with the intracytoplasmic deposition of aggregate-prone proteins in neurons. Autophagy is a powerful process for removing such proteins. In this Review, we consider how certain neurodegenerative diseases may be associated with impaired autophagy and how this may affect pathology. We also discuss how autophagy induction may be a plausible therapeutic strategy for some conditions and review studies in various models that support this hypothesis. Finally, we briefly describe some of the signaling pathways that may be amenable to therapeutic targeting for these goals.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1172/jci73944

Cites

153 of 153 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Molecular and histopathologic analyses of patient tissues demonstrate mislocalized or accumulated autophagy machinery, pathogenic mutations underlying familial neurodegenerative diseases disable known autophagy-related factors, and genetically ablating autophagy effectors produces neurodegeneration in cell and animal model systems, supporting a role for autophagy dysfunction in age-related neurode

    “Molecular and histopathologic analyses of patient tissues demonstrate mislocalized or accumulated autophagy machinery, pathogenic mutations underlying familial neurodegenerative diseases disable known autophagy-related factors, and genetically ablating autophagy effectors produce neurodegeneration in cell and animal model systems [74–81], supporting a role for autophagy dysfunction in the devel”
  • Autophagy proteins have been shown to impact the clearance of protein aggregates in neurons, most likely by canonical aggrephagy.

    “While autophagy proteins have been shown to impact the clearance of protein aggregates in neurons, most likely by the canonical autophagic process of aggrephagy (Frake et al., 2015; Menzies et al., 2017; Qaisiya et al., 2017; Sarkar et al., 2007; Sarkar et al., 2009; Webb et al., 2003; Yamamoto and Simonsen, 2011), effects in microglia of the CNS are more likely due to LANDO.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Part of this paper’s reference list could not be split into single entries.

1 retracted

Flagged first, then by citations

Research works printed but not linked: 2

  1. Rubinsztein DC, Shpilka T, Elazar Z. Mecha- nisms of autophagosome biogenesis. Curr Biol. 2012;22(1):R29-R34.
  2. Rubinsztein DC. The roles of intracellular pro- tein-degradation pathways in neurodegenera- tion. Nature. 2006;443(7113):780-786.

Cited by

Sorted by citations

Authors
Frake, R. A., Ricketts, T., Menzies, F. M., & Rubinsztein, D. C.
Corresponding author
Rubinsztein, David C.
Venue
Journal of Clinical Investigation
Published
2015-01-02
Volume
125
Issue
1
Pages
65-74
ISSN
0021-9738 (ISSN-L)
OpenAlex
W2029582543
Cited by
332
References
153
Citations by year
2026: 17 · 2025: 14 · 2024: 19 · 2023: 28 · 2022: 18 · 2021: 36 · 2020: 38 · 2019: 30 · 2018: 40 · 2017: 37 · 2016: 36 · 2015: 19
FWCI
5.72
Type
journal article
Language
en
Open access
Locations
  • Journal of Clinical Investigation (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Apollo (University of Cambridge) (submittedVersion)
Funders
  • Wellcome Trust (100140, 095317)
  • National Institute for Health and Care Research
  • Tau Consortium
  • Medical Research Council
  • Cambridge Institute for Medical Research, University of Cambridge
Topics
  • Health Sciences › Medicine › Epidemiology › Autophagy in Disease and Therapy
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords
autophagy, neurodegenerative diseases, protein aggregation, protein clearance, autophagy dysfunction, therapeutic targeting, signaling pathways, neuronal pathology
MeSH terms
Animals, Autophagy, Humans, Neurodegenerative Diseases, Protein Kinase Inhibitors, TOR Serine-Threonine Kinases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review